Format

Send to

Choose Destination
Curr Cancer Drug Targets. 2019;19(2):109-119. doi: 10.2174/1568009618666180530092825.

Cellular Senescence-Inducing Small Molecules for Cancer Treatment.

Author information

1
Institute of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, China.
2
School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu 212013, China.

Abstract

Recently, the chemotherapeutic drug-induced cellular senescence has been considered a promising anti-cancer approach. The drug-induced senescence, which shows both similar and different hallmarks from replicative and oncogene-induced senescence, was regarded as a key determinant of tumor response to chemotherapy in vitro and in vivo. To date, an amount of effective chemotherapeutic drugs that can evoke senescence in cancer cells have been reported. The targets of these drugs differ substantially, including senescence signaling pathways, DNA replication process, DNA damage pathways, epigenetic modifications, microtubule polymerization, senescence-associated secretory phenotype (SASP), and so on. By summarizing senescence-inducing small molecule drugs together with their specific traits and corresponding mechanisms, this review is devoted to inform scientists to develop novel therapeutic strategies against cancer through inducing senescence.

KEYWORDS:

Cancer; DNA damage responses; SASP; senescence; senescence-related signaling pathways; small molecule drugs.

Supplemental Content

Full text links

Icon for Bentham Science Publishers Ltd.
Loading ...
Support Center